0.00Open0.00Pre Close0 Volume0 Open Interest1025.00Strike Price0.00Turnover7291.01%IV-33.97%PremiumJan 3, 2025Expiry Date259.90Intrinsic Value100Multiplier-2DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9961Delta0.0001Gamma--Leverage Ratio-553.4152Theta0.0000Rho0.00Eff Leverage0.0001Vega
Eli Lilly and Co Stock Discussion
US FDA: Revoked Emergency Use Authorization for GSK and Vir Biotechnology's Sotrovimab as of Dec 13 - Website
$Eli Lilly and Co (LLY.US)$
$Eli Lilly and Co (LLY.US)$
No comment yet